<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Med</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Med</journal-id><journal-id journal-id-type="pmc-domain-id">2745</journal-id><journal-id journal-id-type="pmc-domain">jclinmed</journal-id><journal-id journal-id-type="publisher-id">jcm</journal-id><journal-title-group><journal-title>Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2077-0383</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10419839</article-id><article-id pub-id-type="pmcid-ver">PMC10419839.1</article-id><article-id pub-id-type="pmcaid">10419839</article-id><article-id pub-id-type="pmcaiid">10419839</article-id><article-id pub-id-type="pmid">37568557</article-id><article-id pub-id-type="doi">10.3390/jcm12155157</article-id><article-id pub-id-type="publisher-id">jcm-12-05157</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Massive Transfusion Increases Serum Magnesium Concentration</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5638-5315</contrib-id><name name-style="western"><surname>Malinowska</surname><given-names initials="J">Justyna</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af1-jcm-12-05157" ref-type="aff">1</xref><xref rid="af2-jcm-12-05157" ref-type="aff">2</xref><xref rid="c1-jcm-12-05157" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5291-749X</contrib-id><name name-style="western"><surname>Ma&#322;ecka-Gie&#322;dowska</surname><given-names initials="M">Milena</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af1-jcm-12-05157" ref-type="aff">1</xref><xref rid="af3-jcm-12-05157" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pietrucha</surname><given-names initials="K">Katarzyna</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af4-jcm-12-05157" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>G&#243;rska</surname><given-names initials="G">Gabriela</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af4-jcm-12-05157" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kogut</surname><given-names initials="D">Dagmara</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af3-jcm-12-05157" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3694-4076</contrib-id><name name-style="western"><surname>Ciepiela</surname><given-names initials="O">Olga</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af1-jcm-12-05157" ref-type="aff">1</xref><xref rid="af3-jcm-12-05157" ref-type="aff">3</xref><xref rid="c1-jcm-12-05157" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>De Angelis</surname><given-names initials="V">Vincenzo</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Bolcato</surname><given-names initials="M">Matteo</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Rodriguez</surname><given-names initials="D">Daniele</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Agostini</surname><given-names initials="V">Vanessa</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-jcm-12-05157"><label>1</label>Department of Laboratory Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland; <email>milena.malecka@wum.edu.pl</email></aff><aff id="af2-jcm-12-05157"><label>2</label>Doctoral School, Medical University of Warsaw, 02-091 Warsaw, Poland</aff><aff id="af3-jcm-12-05157"><label>3</label>Central Laboratory, Central Teaching Hospital of University Clinical Center, Medical University of Warsaw, 02-097 Warsaw, Poland</aff><aff id="af4-jcm-12-05157"><label>4</label>Students Scientific Group of Laboratory Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland</aff><author-notes><corresp id="c1-jcm-12-05157"><label>*</label>Correspondence: <email>justyna.malinowska@wum.edu.pl</email> (J.M.); <email>olga.ciepiela@wum.edu.pl</email> (O.C.); Tel.: +48-22-599-24-05 (O.C.)</corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>8</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2023</year></pub-date><volume>12</volume><issue>15</issue><issue-id pub-id-type="pmc-issue-id">442990</issue-id><elocation-id>5157</elocation-id><history><date date-type="received"><day>26</day><month>6</month><year>2023</year></date><date date-type="rev-recd"><day>03</day><month>8</month><year>2023</year></date><date date-type="accepted"><day>05</day><month>8</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>07</day><month>08</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>12</day><month>08</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-08-14 09:25:09.903"><day>14</day><month>08</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 by the authors.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jcm-12-05157.pdf"/><abstract><p>(1) Background: The massive transfusion of packed red blood cells (RBCs) is a lifesaving procedure, but it is associated with complications, e.g., dysmagnesemia. Since magnesium is an intracellular ion, the transfused RBCs can significantly influence the magnesium concentration in the recipient&#8217;s blood. (2) Methods: A retrospective study was performed among 49 patients hospitalized in the Central Clinical Hospital of the Medical University of Warsaw who received a massive blood transfusion (&#8805;4 units/h). Data on laboratory results and patient history were collected from the hospital database. The intracellular RBCs magnesium concentration was measured in 231 samples using the colorimetric method. (3) Results: There were statistically significant changes in the mean serum magnesium concentration preoperatively and 24 h postoperatively (0.87 &#177; 0.13 vs. 1.03 &#177; 0.14, <italic toggle="yes">p</italic> &lt; 0.00001) and 48 h postoperatively (0.87 &#177; 0.13 vs. 1.06 &#177; 0.15, <italic toggle="yes">p</italic> &lt; 0.00001). Patients who died had significantly higher serum magnesium concentrations (<italic toggle="yes">p</italic> &lt; 0.05). The median intracellular magnesium concentration in RBCs was 0.91 (0.55&#8211;1.8) mmol/L, which is below the reference values of 1.65&#8211;2.65 mmol/L. (4) Conclusions: Transfused RBCs significantly increased the serum magnesium concentration 24 h and 48 h postoperatively. It could be a result of mild hemolysis, as the median intracellular magnesium concentration in RBCs was below the reference values.</p></abstract><kwd-group><kwd>magnesium</kwd><kwd>hypomagnesemia</kwd><kwd>transfusion</kwd><kwd>RBC</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-jcm-12-05157"><title>1. Introduction</title><p>Massive transfusions of red blood cells (RBCs) are performed on patients in hemorrhagic shock and with other life-threatening conditions [<xref rid="B1-jcm-12-05157" ref-type="bibr">1</xref>]. Although their use is vital for patients to survive, it is associated with numerous serious health problems such as hypothermia, coagulopathies, and metabolic and electrolyte disturbances [<xref rid="B2-jcm-12-05157" ref-type="bibr">2</xref>,<xref rid="B3-jcm-12-05157" ref-type="bibr">3</xref>,<xref rid="B4-jcm-12-05157" ref-type="bibr">4</xref>]. The last may result from previously existing disorders in the patient or blood donor, changes in blood products resulting from their prolonged storage, or a loss of minerals related to the method of blood product preparation [<xref rid="B5-jcm-12-05157" ref-type="bibr">5</xref>]. To avoid clotting, the blood is collected into bags containing the anticoagulant citrate phosphate dextrose (CPD) [<xref rid="B6-jcm-12-05157" ref-type="bibr">6</xref>]. Citrate is a magnesium chelator that lowers the extracellular concentration of this mineral [<xref rid="B7-jcm-12-05157" ref-type="bibr">7</xref>].</p><p>Electrolyte disorders are a common massive transfusion complication; however, it is not known how often they are caused by dysmagnesemia in blood products. For severely ill patients, magnesium balance disturbances are commonly diagnosed already on hospital admission, seemingly increasing the importance of the high quality of blood products [<xref rid="B8-jcm-12-05157" ref-type="bibr">8</xref>]. One of the main reasons for magnesium imbalances is chronic kidney disease (CKD), as kidney function is vital for proper magnesium handling [<xref rid="B9-jcm-12-05157" ref-type="bibr">9</xref>]. However, it is not until stages 4 and 5 of CKD that those abnormalities, mostly hypermagnesemia, are visible in laboratory test results because of the compensatory mechanisms [<xref rid="B10-jcm-12-05157" ref-type="bibr">10</xref>]. Although hypermagnesemia is thought to be rare, it is an important in-hospital mortality risk factor [<xref rid="B11-jcm-12-05157" ref-type="bibr">11</xref>,<xref rid="B12-jcm-12-05157" ref-type="bibr">12</xref>]. Moreover, decreased serum magnesium levels, which occur in 9&#8211;15% of critically ill patients, are also associated with an increased risk of death [<xref rid="B8-jcm-12-05157" ref-type="bibr">8</xref>,<xref rid="B13-jcm-12-05157" ref-type="bibr">13</xref>]. Hypomagnesemia is a common electrolyte disturbance occurring after severe events, like cardiac arrests [<xref rid="B14-jcm-12-05157" ref-type="bibr">14</xref>]. However, it also seems to be one of the disturbances following surgeries in general and cardiac surgery, after which magnesium levels fall within the first 24 h [<xref rid="B15-jcm-12-05157" ref-type="bibr">15</xref>,<xref rid="B16-jcm-12-05157" ref-type="bibr">16</xref>].</p><p>Magnesium homeostasis disorders in hospitalized patients may be a result of the drugs and procedures applied. Among the drugs most commonly used in severely ill patients, diuretics and antimicrobials have the biggest impact on magnesium metabolism, as they increase its renal excretion. Moreover, medications taken by patients for chronic illnesses, e.g., cisplatin, calcineurin inhibitors, cetuximab, panitumumab, matuzumab, proton-pump inhibitors, foscarnet, cardiac glycosides, and loop and thiazide diuretics, cause magnesium deficiency [<xref rid="B8-jcm-12-05157" ref-type="bibr">8</xref>,<xref rid="B17-jcm-12-05157" ref-type="bibr">17</xref>,<xref rid="B18-jcm-12-05157" ref-type="bibr">18</xref>]. Continuous veno&#8211;venous hemodiafiltration (CVVHDF) also decreases the serum magnesium concentration because the citrate used in this procedure in order to prevent blood from clotting is also a magnesium chelator [<xref rid="B19-jcm-12-05157" ref-type="bibr">19</xref>,<xref rid="B20-jcm-12-05157" ref-type="bibr">20</xref>].</p><p>Magnesium disturbances also occur in healthy people, some of whom decide to donate blood. According to WHO, 75% of US citizens do not meet their dietary magnesium requirements [<xref rid="B4-jcm-12-05157" ref-type="bibr">4</xref>]. Therefore, it is likely that magnesium deficiency is common in healthy subjects, although difficult to detect in laboratory tests, as only 0.3% of magnesium is in the extracellular space, e.g., serum [<xref rid="B21-jcm-12-05157" ref-type="bibr">21</xref>,<xref rid="B22-jcm-12-05157" ref-type="bibr">22</xref>]. Moreover, the intracellular magnesium concentration in packed RBCs seems to reflect the body&#8217;s magnesium status more precisely than the serum magnesium concentration [<xref rid="B23-jcm-12-05157" ref-type="bibr">23</xref>]. Because of the fact that magnesium is an intracellular ion, the transfused red blood cells (RBCs) can significantly influence the magnesium concentration in the recipient&#8217;s blood. Furthermore, the volume of transfused blood products is correlated with the observed change in the serum magnesium concentration [<xref rid="B24-jcm-12-05157" ref-type="bibr">24</xref>,<xref rid="B25-jcm-12-05157" ref-type="bibr">25</xref>].</p><p>This study aims to assess how the massive transfusion of packed red blood cells (RBCs) influences the patients&#8217; postoperative serum magnesium concentration and how often blood products have abnormal intracellular magnesium concentrations.</p></sec><sec id="sec2-jcm-12-05157"><title>2. Materials and Methods</title><p>A retrospective study was performed among 49 patients hospitalized in the Central Clinical Hospital of the Medical University of Warsaw between November 2021 and March 2023 who received a massive blood transfusion. Massive transfusions were defined as transfusions with &#8805;four units during a single hour. The cut-off point is based on the observations of other studies and adopted due to the lack of a universally accepted massive transfusion definition [<xref rid="B26-jcm-12-05157" ref-type="bibr">26</xref>,<xref rid="B27-jcm-12-05157" ref-type="bibr">27</xref>]). The median volume of transfused packed RBCs was 2600 mL (2350; 2950). The size of the study group was determined based on the study of Chrun et al. (power (1-&#946; err prob) = 0.95) [<xref rid="B24-jcm-12-05157" ref-type="bibr">24</xref>]. The inclusion criteria were the serum magnesium concentration measured preoperatively on admission and 24 h or 48 h postoperatively and the preserved samples of transfused red blood cells (RBCs). The exclusion criteria were data gaps and a history of prior blood transfusions. There were no acute posttransfusion reactions, neither immunological nor non-immunological, including hemolysis, in any of the patients included in the study.</p><p>The study was conducted in accordance with the rules of the Bioethical Committee of the Medical University of Warsaw, and the data were anonymized.</p><p>The data on the serum magnesium concentration preoperatively, 24 h postoperatively, or 48 h postoperatively, the potassium concentration 24 h postoperatively, the creatinine concentration, the eGFR, the reason for hospitalization, the drugs administered intravenously, chronic illnesses, and outcomes were collected from the hospital database.</p><p>Preparation of red blood cells: samples of packed RBCs for transfusion were centrifuged for 15 min at 1500&#215; <italic toggle="yes">g</italic>. The preservative fluid was then separated, and a lysis buffer containing no Mg2+ ions with a pH of 9.4 was added to the remaining red blood cell concentrate in a 1:2 ratio. The samples were then homogenized and subjected to a magnesium concentration measurement. We also measured the total magnesium concentration in the separated preservative fluid.</p><p>The total magnesium in red blood cells as well as in serum and preservative fluid was measured using the colorimetric method. The reference values for the total serum magnesium for adults are in the range of 0.75&#8211;1.0 mmol/L. The reference values of the RBCs intracellular magnesium concentration are in the range of 1.65&#8211;2.65 mmol/L and were drawn from Costello et al.&#8217;s study [<xref rid="B28-jcm-12-05157" ref-type="bibr">28</xref>]. The potassium concentration was measured with the indirect potentiometry method and adjusted mathematically to a standardized pH of 7.4. The reference values for potassium for adults are in the range of 3.5&#8211;5.1 mmol/L. The creatinine concentration was measured using the CRE2 assay in the biochemical Dimension system. The reference values for females are in the range of 0.48&#8211;0.93 mg/dL, and for males, they are in the range of 0.63&#8211;1.16 mg/dL [<xref rid="B29-jcm-12-05157" ref-type="bibr">29</xref>]. The eGRF value was calculated from the CKD-EPI formula. The eGFR value was used to determine the stage of chronic kidney disease&#8212;respectively, stages 1&#8211;2, eGFR &#8805; 60 mL/min/1.73 m<sup>2</sup>, stage 3, eGFR = 30&#8211;59 mL/min/1.73 m<sup>2</sup>, stage 4, eGFR = 15&#8211;29 mL/min/1.73 m<sup>2</sup>, and stage 5, eGFR &lt; 15 mL/min/1.73 m<sup>2</sup> [<xref rid="B30-jcm-12-05157" ref-type="bibr">30</xref>].</p><p>The analyzers used to take measurements were the Cobas 702 (Hoffmann-La Roche AG, Basel, Switzerland), Dimension EXL (Siemens Healthineers, Erlangen, Germany), and ABL 875 FLEX analyzer by Radiometer (Copenhagen, Denmark). For the Dimension EXL analyzer, the measurement range was 0.0&#8211;20.0 mg/dL (0.0&#8211;8.22 mmol/L), and the precision was high (coefficient of variation (CV) 1.7&#8211;1.9%). For the Cobas 702 analyzer, the measurement range was 0.10&#8211;2.0 mmol/L (0.243&#8211;4.86 mg/dL), and the precision was also high (coefficient of variation (CV) 0.7&#8211;1.3%).</p><p>Statistical Analysis was performed using Microsoft Office Excel 2019 and Statsoft Statistica 13.3. The tests used were: a <italic toggle="yes">t</italic>-Student test, Mann&#8211;Whitney test, ANOVA test, Chi-squared test, and Spearman&#8217;s correlation coefficient. The Shapiro&#8211;Wilk test was used to assess the normality of the result distribution. A <italic toggle="yes">p</italic>-value &lt; 0.05 was considered as statistically significant.</p></sec><sec sec-type="results" id="sec3-jcm-12-05157"><title>3. Results</title><p>The mean age of the patients included in the study was 55.7 &#177; 16.2 years, and 20 of them (41%) were female. The majority of the study group (80%, n = 39) consisted of patients operated on for various reasons (heart or aortic defect, cancer, organ transplant, multi-site trauma). The rest (20%, n = 10) consisted of patients that needed packed RBCs transfusion due to severe anemia or bleeding. Only 10% (n = 5) of the study group did not have chronic illnesses, and 27% (n = 13) of the patients died. For basic information on the patients, see <xref rid="jcm-12-05157-t001" ref-type="table">Table 1</xref>.</p><p>Preoperative magnesium concentration abnormalities, although present in 15 patients (31%), were not severe. Patients with hypomagnesemia (n = 7, 14%) had a mean serum magnesium concentration of 0.67 &#177; 0.03 mmol/L, while patients with hypermagnesemia (n = 8, 16%) had one of 1.06 &#177; 0.05 mmol/L.</p><p>The influence of factors that could potentially affect magnesium homeostasis such as undergoing a surgical procedure, comorbidities, drugs administered intravenously, and dialysis on the serum magnesium concentration was analyzed. Statistically significant associations were found only for sedatives and antidiuretics administration. The mean serum magnesium concentration was higher in patients who received sedatives (respectively, 1.07 vs. 0.98, <italic toggle="yes">p</italic> &lt; 0.05, and 1.11 vs. 1.02, <italic toggle="yes">p</italic> &lt; 0.05) as well as in patients who received diuretics (1.105 vs. 1.00, <italic toggle="yes">p</italic> &lt; 0.05, 1.15 vs. 1.04, <italic toggle="yes">p</italic> &lt; 0.05). The results are summarized in <xref rid="jcm-12-05157-t002" ref-type="table">Table 2</xref>.</p><p>The mean preoperative serum magnesium concentration was significantly lower than 24 h postoperative (0.87 &#177; 0.13 vs. 1.02 &#177; 0.14, <italic toggle="yes">p</italic> &lt; 0.00001) and 48 h postoperative (0.87 &#177; 0.13 vs. 1.06 &#177; 0.15, <italic toggle="yes">p</italic> &lt; 0.00001) values (<xref rid="jcm-12-05157-f001" ref-type="fig">Figure 1</xref>A,B). There was a strong correlation between the postoperative serum magnesium concentration and the volume of transfused packed RBCs (R = 0.66, <italic toggle="yes">p</italic> &lt; 0.05).</p><p>Moreover, the incidence of hypermagnesemia increased significantly after a blood transfusion from 16% (n = 8) of the study group up to 57% (n = 28) 24 h postoperatively and 67% (n = 33) 48 h postoperatively (<xref rid="jcm-12-05157-f002" ref-type="fig">Figure 2</xref>).</p><p>There was no association between the preoperative serum magnesium concentration and the outcome (<italic toggle="yes">p</italic> = 0.13). However, there were statistically significant associations between the 24 h and 48 h postoperative serum magnesium concentrations and the outcome. In both cases, patients who died had higher serum magnesium concentrations (<xref rid="jcm-12-05157-f003" ref-type="fig">Figure 3</xref>A). Moreover, hypermagnesemia 24 h and 48 h postoperatively was found significantly more often in patients who died (<xref rid="jcm-12-05157-f003" ref-type="fig">Figure 3</xref>B,C).</p><p>As kidney function influences the serum magnesium concentration, data on the creatinine and eGFR of patients included in the study were collected. Increased creatinine levels were common, occurring in 60% of the female patients (n = 12), with a median of 1.40 (0.94, 4.49) mg/dL, and in 59% of male patients (n = 17), with a median of 1.86 (1.17, 4.02) mg/dL. However, there was no statistically significant association with sex (<italic toggle="yes">p</italic> = 0.24). Since only a few patients bleeding at admission were reported, an increased creatinine concentration in the majority of patients was not associated with hypovolemia.</p><p>Despite the increased creatinine levels among the patients included in the study, the majority of our study group (84%, n = 41) had an eGFR in a range of one to three stages of CKD, and only one-fifth (n = 8) had advanced CKD (stages 4&#8211;5).</p><p>However, there was a statistically significant average negative correlation between the preoperative magnesium concentration and eGFR R = &#8722;0.34 (<italic toggle="yes">p</italic> &lt; 0.05). On the other hand, there was no statistically significant correlation between the preoperative magnesium and creatinine concentrations (R = 0.26, <italic toggle="yes">p</italic> = 0.07). Furthermore, no statistically significant correlation was found between either the total serum magnesium concentration 24 h postoperatively and creatinine (R = 0.24, <italic toggle="yes">p</italic> = 0.1077) or eGFR (R = &#8722;0.24, <italic toggle="yes">p</italic> = 0.1), nor was there one between the serum magnesium concentration 48 h postoperatively and creatinine (R = 0.26, <italic toggle="yes">p</italic> = 0.79) or eGRF (R = &#8722;0.28, <italic toggle="yes">p</italic> = 0.55).</p><p>There was also no statistically significant difference in the mean preoperative, 24 h, and 48 h postoperative serum magnesium concentrations between the CKD stages, respectively (<italic toggle="yes">p</italic> = 0.68, <italic toggle="yes">p</italic> = 0.0675, <italic toggle="yes">p</italic> = 0.0538). Among patients that had an abnormal preoperative serum magnesium concentration and advanced CKD with an eGFR lower than 29 (stages four to five), only one had hypermagnesemia.</p><p>The intracellular magnesium concentration was measured in 231 packed RBC samples. The median intracellular magnesium concentration in packed RBCs was 0.91 (0.55&#8211;1.8) mmol/L, which is below the reference values of 1.65&#8211;2.65 mmol/L (18), whereas the mean magnesium concentration in the preservative fluid was 0.214 &#177; 0.036 mmol/L. Magnesium levels below the reference values range were found in 198 (86%) samples, with a median concentration of 0.9 (0.24&#8211;1.62) mmol/L; normomagnesemia was found in 32 (14%) samples, with a median concentration of 1.95 (1.66&#8211;2.4) mmol/L. There were no samples with hypermagnesemia.</p><p>No correlation between the mean intracellular magnesium concentration in transfused RBCs and the change in the serum magnesium concentration 24 h (R = 0.24, <italic toggle="yes">p</italic> = 0.1) and 48 h (R = 0.008, <italic toggle="yes">p</italic> = 0.95) (Spearman&#8217;s correlation coefficient) postoperatively was found.</p><p>To confirm that the observed changes in the serum magnesium concentration were not due to noninfectious transfusion-associated adverse events, potassium levels preoperatively and 24 h postoperatively were also analyzed. The mean potassium concentration in our study group was 3.98 &#177; 0.6 mmol/L preoperatively and 4.47 &#177; 0.67 mmol/L 24 h postoperatively. The hypokalemia prevalence decreased postoperatively from 22% (n = 11) to 12% (n = 6) of the study group, whereas the hyperkalemia prevalence increased from 2% (n = 1) to 20% (n = 10) of the enrolled patients. Out of those patients, 10 had hypermagnesemia. There was no association between hypermagnesemia occurrence and serum potassium concentration either 24 h postoperatively (<italic toggle="yes">p</italic> = 0.18) or 48 h postoperatively (<italic toggle="yes">p</italic> = 0.36).</p></sec><sec sec-type="discussion" id="sec4-jcm-12-05157"><title>4. Discussion</title><p>In our study, preoperative serum magnesium concentration disturbances were found in 31% of patients, with hypermagnesemia being more common than hypomagnesemia&#8212;16% and 14% of patients, respectively. Hypermagnesemia, although thought to be rare, is a condition with an incidence of 1.78&#8211;10% in the hospital population [<xref rid="B31-jcm-12-05157" ref-type="bibr">31</xref>,<xref rid="B32-jcm-12-05157" ref-type="bibr">32</xref>]. However, it seems to be substantially more frequent in the ICU department, with the incidence reaching 39.8% [<xref rid="B33-jcm-12-05157" ref-type="bibr">33</xref>]. On the other hand, hypomagnesemia is usually found in a larger proportion of hospitalized patients, 8.43&#8211;15%, which is in line with the incidence observed in our study group [<xref rid="B31-jcm-12-05157" ref-type="bibr">31</xref>,<xref rid="B32-jcm-12-05157" ref-type="bibr">32</xref>].</p><p>Maintaining magnesium homeostasis requires shifts of magnesium ions between the intracellular and extracellular spaces [<xref rid="B34-jcm-12-05157" ref-type="bibr">34</xref>]. Serum magnesium levels are also tightly regulated by kidneys, intestines, and bones [<xref rid="B33-jcm-12-05157" ref-type="bibr">33</xref>]. However, in critically ill patients, neither regulatory mechanisms nor insulin supply function properly. Additionally, organ dysfunctions are frequent [<xref rid="B34-jcm-12-05157" ref-type="bibr">34</xref>]. Improper kidney function is one of the main causes of dysmagnesemia. Renal wasting results in hypomagnesemia, and decreased glomerular filtration causes hypermagnesemia. The latter can also be a result of cell and tissue damage, sepsis, hypothyroidism, Addison&#8217;s disease, or lithium treatment [<xref rid="B33-jcm-12-05157" ref-type="bibr">33</xref>]. The former can be caused by gastrointestinal abnormalities or medicines, such as loop diuretics, thiazides, cisplatin, or proton pump inhibitors [<xref rid="B8-jcm-12-05157" ref-type="bibr">8</xref>].</p><p>Although 90% of our study group was treated for chronic illnesses before hospitalization (the aforementioned diseases associated with a higher incidence of magnesium homeostasis disorders, among others), there was no association between the presence of comorbidities and the mean serum magnesium concentration at any time of the hospitalization. However, the serum magnesium concentration seems to be a better tool for observing sudden changes in the body than for the assessment of its magnesium status [<xref rid="B12-jcm-12-05157" ref-type="bibr">12</xref>]. However, there were associations between the 24 h and 48 h postoperative serum magnesium concentrations and sedatives and diuretics intravenous administration. In both cases, patients who received medications had higher serum magnesium concentrations. Based on the literature data, sedative drugs do not affect magnesium homeostasis; however, not every patient in our study group received a sedative drug. Therefore, the study group may be too small to draw valid conclusions from this observation [<xref rid="B35-jcm-12-05157" ref-type="bibr">35</xref>,<xref rid="B36-jcm-12-05157" ref-type="bibr">36</xref>,<xref rid="B37-jcm-12-05157" ref-type="bibr">37</xref>]. As for loop diuretics, e.g., furosemide, which was most commonly administered to patients in our study group, their use was also associated with an increased serum magnesium concentration in a study by Kieboom et al. [<xref rid="B38-jcm-12-05157" ref-type="bibr">38</xref>].</p><p>There was no significant difference in the serum magnesium concentration between patients that were operated on and those that had massive RBCs transfusion administered because of other reasons. This is contrary to the observations of other researchers, who reported a decrease in serum magnesium concentrations after surgeries [<xref rid="B8-jcm-12-05157" ref-type="bibr">8</xref>,<xref rid="B15-jcm-12-05157" ref-type="bibr">15</xref>].</p><p>In our study group, 46% of patients had an eGFR of 60 or more, which can already mean CKD stage 1 (90&#8211;60 mL/min/1.73 m<sup>2</sup>) but is still associated with proper kidney function [<xref rid="B39-jcm-12-05157" ref-type="bibr">39</xref>]. Furthermore, another 36% had CKD stage 3, and at this stage, compensatory mechanisms should maintain a normal serum magnesium concentration [<xref rid="B10-jcm-12-05157" ref-type="bibr">10</xref>,<xref rid="B40-jcm-12-05157" ref-type="bibr">40</xref>]. Among patients with advanced CKD (eGFR &lt; 30), only one had hypermagnesemia, and no one had hypomagnesemia. Additionally, we did not find statistically significant differences in the serum magnesium concentration between patients at different stages of CKD, which is contrary to the results of Coburn et al. [<xref rid="B41-jcm-12-05157" ref-type="bibr">41</xref>]. However, advanced CKD was not common in our study group, so we can only state that decreased glomerular filtration was not associated with an increased pre- or postoperative serum magnesium concentration in our study. Although around 60% of enrolled patients had increased creatinine levels, it is not the best indicator of kidney function, as an elevated creatinine concentration can be caused by a diet rich in animal protein, large muscle mass, and some medicaments [<xref rid="B39-jcm-12-05157" ref-type="bibr">39</xref>]. Additionally, in most patients from our study group, the abnormal serum magnesium levels did not develop until post-transfusion.</p><p>Massive blood transfusion resulted in a significantly elevated incidence of hypermagnesemia both 24 h and 48 h postoperatively (<italic toggle="yes">p</italic> &lt; 0.00001). Furthermore, there was a strong correlation between the volume of transfused packed RBCs and the serum magnesium concentration (R = 0.66, <italic toggle="yes">p</italic> &lt; 0.05). This result is in stark contrast to those obtained by other researchers, who found a significant reduction in the concentration of magnesium in the serum of patients after blood transfusion [<xref rid="B24-jcm-12-05157" ref-type="bibr">24</xref>,<xref rid="B25-jcm-12-05157" ref-type="bibr">25</xref>]. Moreover, elevated magnesium levels were associated with the outcome. In our study, patients who died had significantly higher serum concentrations of magnesium both 24 h and 48 h postoperatively. Moreover, hypermagnesemia was more common in patients who died. This is in line with our earlier studies&#8217; results but also with other researchers&#8217; observations [<xref rid="B11-jcm-12-05157" ref-type="bibr">11</xref>,<xref rid="B33-jcm-12-05157" ref-type="bibr">33</xref>,<xref rid="B42-jcm-12-05157" ref-type="bibr">42</xref>,<xref rid="B43-jcm-12-05157" ref-type="bibr">43</xref>,<xref rid="B44-jcm-12-05157" ref-type="bibr">44</xref>].</p><p>One plausible explanation is that the increased postoperative serum magnesium concentration was a result of hemolysis, as it would release magnesium ions. Hemolytic transfusion reactions are listed among noninfectious transfusion complications [<xref rid="B45-jcm-12-05157" ref-type="bibr">45</xref>]. Acute hemolysis is always caused by an immune reaction and happens within 24 h of transfusion. However, it is a rather rare complication with an incidence of 1 to 5 per 50,000 transfusions. In our study group, hypermagnesemia affected 57% of patients 24 h postoperatively and 67% of patients 48 h postoperatively [<xref rid="B46-jcm-12-05157" ref-type="bibr">46</xref>]. Acute complications associated with massive blood transfusion also include hypo- and hyperkalemia [<xref rid="B2-jcm-12-05157" ref-type="bibr">2</xref>]. However, those disturbances were not common, as hypokalemia was found in 12% and hyperkalemia was found in 20% of the patients. Notwithstanding, hemolysis may be caused by other factors, such as fluid warmers [<xref rid="B47-jcm-12-05157" ref-type="bibr">47</xref>]. The warming of fluids during transfusion is a procedure performed in order to avoid hypothermia, another blood transfusion complication. Blood warming is generally safe and causes only mild hemolysis, with no clinical impact on the patients [<xref rid="B47-jcm-12-05157" ref-type="bibr">47</xref>]. Moreover, it would explain why the serum magnesium concentration increased postoperatively, even though hypomagnesemia was found in 86% of packed red cells.</p><p>An intracellular magnesium concentration below the reference values range is an indicator of a low body magnesium status [<xref rid="B14-jcm-12-05157" ref-type="bibr">14</xref>]. Although it was believed for years that the intracellular magnesium concentration is stable, it is now known that the concentration of magnesium inside the cells can be influenced by hormones and other factors and even due to a decreased concentration in the blood serum, which causes the displacement of ions from the intracellular to the extracellular space [<xref rid="B23-jcm-12-05157" ref-type="bibr">23</xref>,<xref rid="B48-jcm-12-05157" ref-type="bibr">48</xref>]. While hypomagnesemia in RBCs can be a result of the low body magnesium status of a donor, it can also be caused by ex vivo changes due to the production process and storage [<xref rid="B49-jcm-12-05157" ref-type="bibr">49</xref>]&#8212;for example, the usage of anticoagulants and additional solutions that extend the durability of the preparation [<xref rid="B5-jcm-12-05157" ref-type="bibr">5</xref>]. All of those currently in use have an acidic pH (&#8764;5.6&#8211;5.8), whereas the physiological pH of blood is 7.3. During the first days of storage, the buffering capacity of the RBC allows them to adjust the pH, but it does not last for long. The pH of RBC increases gradually to approximately 6.5 after 6 weeks of storage [<xref rid="B50-jcm-12-05157" ref-type="bibr">50</xref>]. This lower pH value alters the generation of adenosine 5&#8242;-triphosphate (ATP), vital for RBC&#8217;s survival, and 2,3-diphosphoglycerate (2,3-DPG), needed for oxygen transportation. Furthermore, RBCs&#8217; biochemistry changes in this altered environment, including mechanisms of ion and osmotic channels [<xref rid="B51-jcm-12-05157" ref-type="bibr">51</xref>]. Another issue is that RBCs&#8217; susceptibility to storage-related damage may be linked to a donor. Lifestyle components, like physical activity, diet, alcohol consumption, and smoking, but also age and sex, influence the RBCs quality [<xref rid="B52-jcm-12-05157" ref-type="bibr">52</xref>,<xref rid="B53-jcm-12-05157" ref-type="bibr">53</xref>,<xref rid="B54-jcm-12-05157" ref-type="bibr">54</xref>,<xref rid="B55-jcm-12-05157" ref-type="bibr">55</xref>].</p><p>Among the measures used to assess the RBCs quality, the main focus is on the refrigerator temperature, residual leucocyte counts, and visible hemolysis. Biochemical ones, like ATP, 2,3-DGP, potassium, and calcium levels, also have such applications but are not so widely used, as they require more specialized methods of measurement and do not reflect all storage-related changes [<xref rid="B56-jcm-12-05157" ref-type="bibr">56</xref>]. On the other hand, the magnesium concentration in blood products is not measured at all. For that reason, the comparison of the obtained results with those of other researchers is not possible. However, if the mean magnesium concentration in the preservative fluid was 0.214 &#177; 0.036 mmol/L, magnesium ions probably had not shifted from the intracellular to the extracellular space, and the reason for hypomagnesemia in transfused RBCs could be the hypomagnesemia of the donors.</p><p>Hypomagnesemia in healthy people, as blood donors must be, is usually a result of an inadequate magnesium intake [<xref rid="B57-jcm-12-05157" ref-type="bibr">57</xref>]. This can be partly explained by the fact that soils are less rich in this mineral, and therefore, the magnesium content of agricultural produce is lower than it used to be. In addition, some magnesium is lost through food processing, which makes it difficult to meet the demand for this mineral [<xref rid="B58-jcm-12-05157" ref-type="bibr">58</xref>]. Another factor that could be the cause of common hypomagnesemia in healthy people who decided to donate blood is stress [<xref rid="B59-jcm-12-05157" ref-type="bibr">59</xref>]. There is a concept of a magnesium and stress vicious circle, in which stress causes increased magnesium loss and, as a result, its deficiency, which in turn negatively impacts the body&#8217;s response to stressors [<xref rid="B60-jcm-12-05157" ref-type="bibr">60</xref>]. This theory fits the fact that magnesium deficiency and stress affect an increasing part of developed societies, and the symptoms of both of these conditions are very similar, including fatigue, irritability, gastrointestinal disorders, and headaches [<xref rid="B59-jcm-12-05157" ref-type="bibr">59</xref>]. However, the diagnosis of this disorder may be a matter of the cut-off points used, as there is still some uncertainty about the values that should be adopted when trying to assess the magnesium concentration in RBCs [<xref rid="B23-jcm-12-05157" ref-type="bibr">23</xref>].</p><p>The lack of a correlation between the mean magnesium concentration in transfused RBCs and the change in the serum magnesium concentration 24 h and 48 h postoperatively could be a result of mild hemolysis, which is suspected to be the reason for the postoperatively increased serum magnesium concentration. The release of intracellular magnesium cations could temporarily increase the concentration of this mineral in the serum and mask the effect of mostly hypomagnesemic transfused red blood cells.</p><p>The study has certain strengths that are worth mentioning. First, to our knowledge, it is the first study to assess changes in the serum magnesium concentration after transfusion while assessing the magnesium concentration in packed RBCs that were used for transfusion at the same time. Second, there are limited data on abnormal intracellular concentrations of magnesium in healthy people, and our results might shed some light on this matter.</p></sec><sec sec-type="conclusions" id="sec5-jcm-12-05157"><title>5. Conclusions</title><p>Massive blood transfusions significantly affect the serum magnesium concentration; however, it may rather be a result of mild hemolysis than an influence of the intracellular magnesium concentration in packed red cells. The postoperative serum magnesium concentration was higher, and hypermagnesemia was significantly more prevalent in patients who died. Therefore, it might be a parameter that should be monitored in patients after massive transfusions. Despite the common intracellular deficit of magnesium in packed red blood cells, its concentration does not influence magnesium levels in the extracellular fluid of transfused patients.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, O.C.; methodology, O.C. and J.M.; software, M.M.-G. and J.M.; validation, M.M.-G. and O.C.; formal analysis, J.M.; investigation, J.M., M.M.-G., K.P., G.G. and D.K.; resources, O.C. and M.M.-G.; data curation, O.C.; writing&#8212;original draft preparation, J.M.; writing&#8212;review and editing, M.M.-G., K.P., G.G., D.K. and O.C.; visualization, J.M. and O.C.; supervision, O.C.; project administration, J.M., O.C. and M.M.-G. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable due to the study&#8217;s retrospective nature.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are available on request from the corresponding author. The data are not publicly available due to ethical reasons.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-jcm-12-05157"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abuzeid</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>O&#8217;keeffe</surname><given-names>T.</given-names></name></person-group><article-title>Review of massive transfusion protocols in the injured, bleeding patient</article-title><source>Curr. Opin. Crit. Care</source><year>2019</year><volume>25</volume><fpage>661</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.1097/MCC.0000000000000668</pub-id><pub-id pub-id-type="pmid">31574016</pub-id></element-citation></ref><ref id="B2-jcm-12-05157"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sihler</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>Napolitano</surname><given-names>L.M.</given-names></name></person-group><article-title>Complications of Massive Transfusion</article-title><source>Chest</source><year>2010</year><volume>137</volume><fpage>209</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1378/chest.09-0252</pub-id><pub-id pub-id-type="pmid">20051407</pub-id></element-citation></ref><ref id="B3-jcm-12-05157"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayter</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Pavenski</surname><given-names>K.</given-names></name><name name-style="western"><surname>Baker</surname><given-names>J.</given-names></name></person-group><article-title>Massive transfusion in the trauma patient: Continuing Professional Development</article-title><source>Can. J. Anaesth.</source><year>2012</year><volume>59</volume><fpage>1130</fpage><lpage>1145</lpage><pub-id pub-id-type="pmid">23076727</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12630-012-9795-4</pub-id></element-citation></ref><ref id="B4-jcm-12-05157"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmed</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mohammed</surname><given-names>A.</given-names></name></person-group><article-title>Magnesium: The Forgotten Electrolyte&#8212;A Review on Hypomagnesemia</article-title><source>Med. Sci.</source><year>2019</year><volume>7</volume><fpage>56</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/medsci7040056</pub-id><pub-id pub-id-type="pmcid">PMC6524065</pub-id><pub-id pub-id-type="pmid">30987399</pub-id></element-citation></ref><ref id="B5-jcm-12-05157"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lei</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>L.Z.</given-names></name></person-group><article-title>Perioperative Red Blood Cell Transfusion: What We Do Not Know</article-title><source>Chin. Med. J.</source><year>2015</year><volume>128</volume><fpage>2383</fpage><lpage>2386</lpage><pub-id pub-id-type="doi">10.4103/0366-6999.163384</pub-id><pub-id pub-id-type="pmid">26315088</pub-id><pub-id pub-id-type="pmcid">PMC4733804</pub-id></element-citation></ref><ref id="B6-jcm-12-05157"><label>6.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name name-style="western"><surname>Cross</surname><given-names>A.R.</given-names></name></person-group><article-title>Additives and Anticoagulants</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.lifeblood.com.au/health-professionals/products/additives-anticoagulants" ext-link-type="uri">https://www.lifeblood.com.au/health-professionals/products/additives-anticoagulants</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2022-06-01">(accessed on 1 June 2022)</date-in-citation></element-citation></ref><ref id="B7-jcm-12-05157"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bazzano</surname><given-names>G.</given-names></name><name name-style="western"><surname>Galazzi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Giusti</surname><given-names>G.D.</given-names></name><name name-style="western"><surname>Panigada</surname><given-names>M.</given-names></name><name name-style="western"><surname>Laquintana</surname><given-names>D.</given-names></name></person-group><article-title>The Order of Draw during Blood Collection: A Systematic Literature Review</article-title><source>Int. J. Environ. Res. Public Health</source><year>2021</year><volume>18</volume><elocation-id>1568</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph18041568</pub-id><pub-id pub-id-type="pmid">33562241</pub-id><pub-id pub-id-type="pmcid">PMC7915193</pub-id></element-citation></ref><ref id="B8-jcm-12-05157"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hansen</surname><given-names>B.-A.</given-names></name><name name-style="western"><surname>Bruserud</surname><given-names>&#216;.</given-names></name></person-group><article-title>Hypomagnesemia in critically ill patients</article-title><source>J. Intensiv. Care</source><year>2018</year><volume>6</volume><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/s40560-018-0291-y</pub-id><pub-id pub-id-type="pmid">29610664</pub-id><pub-id pub-id-type="pmcid">PMC5872533</pub-id></element-citation></ref><ref id="B9-jcm-12-05157"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blaine</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chonchol</surname><given-names>M.</given-names></name><name name-style="western"><surname>Levi</surname><given-names>M.</given-names></name></person-group><article-title>Renal control of calcium, phosphate, and magnesium homeostasis</article-title><source>Clin. J. Am. Soc. Nephrol.</source><year>2015</year><volume>10</volume><fpage>1257</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.2215/CJN.09750913</pub-id><pub-id pub-id-type="pmid">25287933</pub-id><pub-id pub-id-type="pmcid">PMC4491294</pub-id></element-citation></ref><ref id="B10-jcm-12-05157"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van de Wal-Visscher</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Kooman</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>van der Sande</surname><given-names>F.M.</given-names></name></person-group><article-title>Magnesium in Chronic Kidney Disease: Should We Care?</article-title><source>Blood Purif.</source><year>2018</year><volume>45</volume><fpage>173</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1159/000485212</pub-id><pub-id pub-id-type="pmid">29478069</pub-id><pub-id pub-id-type="pmcid">PMC6492639</pub-id></element-citation></ref><ref id="B11-jcm-12-05157"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>R.</given-names></name></person-group><article-title>High-Normal Serum Magnesium and Hypermagnesemia Are Associated with Increased 30-Day In-Hospital Mortality: A Retrospective Cohort Study</article-title><source>Front. Cardiovasc. Med.</source><year>2021</year><volume>8</volume><fpage>625133</fpage><pub-id pub-id-type="pmid">33644132</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcvm.2021.625133</pub-id><pub-id pub-id-type="pmcid">PMC7902876</pub-id></element-citation></ref><ref id="B12-jcm-12-05157"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jahnen-Dechent</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ketteler</surname><given-names>M.</given-names></name></person-group><article-title>Magnesium basics</article-title><source>Clin. Kidney J.</source><year>2012</year><volume>5</volume><issue>(Suppl. S1)</issue><fpage>i3</fpage><lpage>i14</lpage><pub-id pub-id-type="doi">10.1093/ndtplus/sfr163</pub-id><pub-id pub-id-type="pmid">26069819</pub-id><pub-id pub-id-type="pmcid">PMC4455825</pub-id></element-citation></ref><ref id="B13-jcm-12-05157"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fairley</surname><given-names>J.</given-names></name><name name-style="western"><surname>Glassford</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bellomo</surname><given-names>R.</given-names></name></person-group><article-title>Magnesium status and magnesium therapy in critically ill patients: A systematic review</article-title><source>J. Crit. Care</source><year>2015</year><volume>30</volume><fpage>1349</fpage><lpage>1358</lpage><pub-id pub-id-type="pmid">26337558</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcrc.2015.07.029</pub-id></element-citation></ref><ref id="B14-jcm-12-05157"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bellomo</surname><given-names>R.</given-names></name><name name-style="western"><surname>M&#228;rtensson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Eastwood</surname><given-names>G.M.</given-names></name></person-group><article-title>Metabolic and electrolyte disturbance after cardiac arrest: How to deal with it</article-title><source>Best Pract. Res. Clin. Anaesthesiol.</source><year>2015</year><volume>29</volume><fpage>471</fpage><lpage>484</lpage><pub-id pub-id-type="pmid">26670818</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bpa.2015.10.003</pub-id></element-citation></ref><ref id="B15-jcm-12-05157"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakayama</surname><given-names>T.</given-names></name><name name-style="western"><surname>Umehara</surname><given-names>K.</given-names></name><name name-style="western"><surname>Shirozu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sumie</surname><given-names>M.</given-names></name><name name-style="western"><surname>Karashima</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Higashi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yamaura</surname><given-names>K.</given-names></name></person-group><article-title>Association between ionized magnesium and postoperative shivering</article-title><source>J. Anesth.</source><year>2021</year><volume>35</volume><fpage>412</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1007/s00540-021-02914-y</pub-id><pub-id pub-id-type="pmid">33682037</pub-id></element-citation></ref><ref id="B16-jcm-12-05157"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ram</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lavee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Shechter</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kogan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Maor</surname><given-names>E.</given-names></name><name name-style="western"><surname>Asher</surname><given-names>E.</given-names></name><name name-style="western"><surname>Freimark</surname><given-names>D.</given-names></name><name name-style="western"><surname>Klempfner</surname><given-names>R.</given-names></name><name name-style="western"><surname>Peled</surname><given-names>Y.</given-names></name></person-group><article-title>Relation of Low Serum Magnesium to Mortality and Cardiac Allograft Vasculopathy Following Heart Transplantation</article-title><source>Am. J. Cardiol.</source><year>2020</year><volume>125</volume><fpage>1517</fpage><lpage>1523</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2020.02.030</pub-id><pub-id pub-id-type="pmid">32238278</pub-id></element-citation></ref><ref id="B17-jcm-12-05157"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lameris</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Monnens</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Bindels</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Hoenderop</surname><given-names>J.G.J.</given-names></name></person-group><article-title>Drug-induced alterations in Mg<sup>2+</sup> homoeostasis</article-title><source>Clin. Sci.</source><year>2012</year><volume>123</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1042/CS20120045</pub-id><pub-id pub-id-type="pmid">22409531</pub-id></element-citation></ref><ref id="B18-jcm-12-05157"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liamis</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hoorn</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Florentin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Milionis</surname><given-names>H.</given-names></name></person-group><article-title>An overview of diagnosis and management of drug-induced hypomagnesemia</article-title><source>Pharmacol. Res. Perspect.</source><year>2021</year><volume>9</volume><fpage>e00829</fpage><pub-id pub-id-type="doi">10.1002/prp2.829</pub-id><pub-id pub-id-type="pmid">34278747</pub-id><pub-id pub-id-type="pmcid">PMC8287009</pub-id></element-citation></ref><ref id="B19-jcm-12-05157"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brain</surname><given-names>M.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Parkes</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fowler</surname><given-names>P.</given-names></name></person-group><article-title>Magnesium flux during continuous venovenous haemodiafiltration with heparin and citrate anticoagulation</article-title><source>Crit. Care Resusc. J. Australas. Acad. Crit. Care Med.</source><year>2012</year><volume>14</volume><fpage>274</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">23230876</pub-id></element-citation></ref><ref id="B20-jcm-12-05157"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko&#347;ka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kowalik</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Lango-Maziarz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Karolak</surname><given-names>W.</given-names></name><name name-style="western"><surname>Jagielak</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lango</surname><given-names>R.</given-names></name></person-group><article-title>Ionic homeostasis, acid-base balance and the risk of citrate accumulation in patients after cardiovascular surgery treated with continuous veno-venous haemofiltration with post-dilution regional citrate anticoagulation&#8212;An observational case-control study</article-title><source>Acta. Biochim. Pol.</source><year>2021</year><volume>68</volume><fpage>695</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">34714613</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18388/abp.2020_5598</pub-id></element-citation></ref><ref id="B21-jcm-12-05157"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ismail</surname><given-names>A.A.A.</given-names></name><name name-style="western"><surname>Ismail</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ismail</surname><given-names>A.A.</given-names></name></person-group><article-title>Chronic magnesium deficiency and human disease; time for reappraisal?</article-title><source>Qjm</source><year>2018</year><volume>111</volume><fpage>759</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1093/qjmed/hcx186</pub-id><pub-id pub-id-type="pmid">29036357</pub-id></element-citation></ref><ref id="B22-jcm-12-05157"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gr&#246;ber</surname><given-names>U.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kisters</surname><given-names>K.</given-names></name></person-group><article-title>Magnesium in Prevention and Therapy</article-title><source>Nutrients</source><year>2015</year><volume>7</volume><fpage>8199</fpage><lpage>8226</lpage><pub-id pub-id-type="doi">10.3390/nu7095388</pub-id><pub-id pub-id-type="pmid">26404370</pub-id><pub-id pub-id-type="pmcid">PMC4586582</pub-id></element-citation></ref><ref id="B23-jcm-12-05157"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Razzaque</surname><given-names>M.S.</given-names></name></person-group><article-title>Magnesium: Are We Consuming Enough?</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><fpage>1863</fpage><pub-id pub-id-type="pmid">30513803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/nu10121863</pub-id><pub-id pub-id-type="pmcid">PMC6316205</pub-id></element-citation></ref><ref id="B24-jcm-12-05157"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chrun</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Jo&#227;o</surname><given-names>P.R.D.</given-names></name></person-group><article-title>Hypomagnesemia after spinal fusion</article-title><source>J. Pediatr.</source><year>2012</year><volume>88</volume><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.2223/JPED.2181</pub-id><pub-id pub-id-type="pmid">22491787</pub-id></element-citation></ref><ref id="B25-jcm-12-05157"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lanzinger</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Moretti</surname><given-names>E.W.</given-names></name><name name-style="western"><surname>Wilderman</surname><given-names>R.F.</given-names></name><name name-style="western"><surname>El-Moalem</surname><given-names>E.H.</given-names></name><name name-style="western"><surname>Toffaletti</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Moon</surname><given-names>E.R.</given-names></name></person-group><article-title>The relationship between ionized and total serum magnesium concentrations during abdominal surgery</article-title><source>J. Clin. Anesth.</source><year>2003</year><volume>15</volume><fpage>245</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">12888158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0952-8180(03)00059-x</pub-id></element-citation></ref><ref id="B26-jcm-12-05157"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moren</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Hamptom</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Diggs</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kiraly</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fox</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Holcomb</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Rahbar</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Brasel</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Bulger</surname><given-names>E.M.</given-names></name><etal/></person-group><article-title>Recursive partitioning identifies greater than 4 U of packed red blood cells per hour as an improved massive transfusion definition</article-title><source>J. Trauma Acute Care Surg.</source><year>2015</year><volume>79</volume><fpage>920</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">26680135</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/TA.0000000000000830</pub-id><pub-id pub-id-type="pmcid">PMC4778543</pub-id></element-citation></ref><ref id="B27-jcm-12-05157"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>V.S.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>E.</given-names></name><name name-style="western"><surname>Yau</surname><given-names>S.</given-names></name><name name-style="western"><surname>Abeyakoon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Seamer</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bhopal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tucker</surname><given-names>H.</given-names></name><name name-style="western"><surname>Doree</surname><given-names>C.</given-names></name><name name-style="western"><surname>Brunskill</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>McQuilten</surname><given-names>Z.K.</given-names></name><etal/></person-group><article-title>Definitions of massive transfusion in adults with critical bleeding: A systematic review</article-title><source>Crit. Care</source><year>2023</year><volume>27</volume><fpage>265</fpage><pub-id pub-id-type="pmid">37407998</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13054-023-04537-z</pub-id><pub-id pub-id-type="pmcid">PMC10324127</pub-id></element-citation></ref><ref id="B28-jcm-12-05157"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costello</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>F.</given-names></name></person-group><article-title>Interpreting magnesium status to enhance clinical care: Key indicators</article-title><source>Curr. Opin. Clin. Nutr. Metab. Care</source><year>2017</year><volume>20</volume><fpage>504</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1097/MCO.0000000000000410</pub-id><pub-id pub-id-type="pmid">28806179</pub-id><pub-id pub-id-type="pmcid">PMC5812344</pub-id></element-citation></ref><ref id="B29-jcm-12-05157"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delanaye</surname><given-names>P.</given-names></name><name name-style="western"><surname>Cavalier</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pottel</surname><given-names>H.</given-names></name></person-group><article-title>Serum Creatinine: Not So Simple!</article-title><source>Nephron</source><year>2017</year><volume>136</volume><fpage>302</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1159/000469669</pub-id><pub-id pub-id-type="pmid">28441651</pub-id></element-citation></ref><ref id="B30-jcm-12-05157"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hill</surname><given-names>N.R.</given-names></name><name name-style="western"><surname>Fatoba</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>Oke</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Hirst</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>O&#8217;Callaghan</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Lasserson</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Hobbs</surname><given-names>F.D.R.</given-names></name></person-group><article-title>Global Prevalence of Chronic Kidney Disease&#8212;A Systematic Review and Meta-Analysis</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0158765</elocation-id><pub-id pub-id-type="pmid">27383068</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0158765</pub-id><pub-id pub-id-type="pmcid">PMC4934905</pub-id></element-citation></ref><ref id="B31-jcm-12-05157"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Catalano</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bellone</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chil&#224;</surname><given-names>D.</given-names></name><name name-style="western"><surname>Loddo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Morabito</surname><given-names>N.</given-names></name><name name-style="western"><surname>Basile</surname><given-names>G.</given-names></name><name name-style="western"><surname>Benvenga</surname><given-names>S.</given-names></name><name name-style="western"><surname>Corica</surname><given-names>F.</given-names></name></person-group><article-title>Rates of hypomagnesemia and hypermagnesemia in medical settings</article-title><source>Magnes. Res.</source><year>2021</year><volume>34</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">34165437</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1684/mrh.2021.0478</pub-id></element-citation></ref><ref id="B32-jcm-12-05157"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheungpasitporn</surname><given-names>W.</given-names></name><name name-style="western"><surname>Thongprayoon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chewcharat</surname><given-names>A.</given-names></name><name name-style="western"><surname>Petnak</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>P.W.</given-names></name><name name-style="western"><surname>Bathini</surname><given-names>T.</given-names></name><name name-style="western"><surname>Vallabhajosyula</surname><given-names>S.</given-names></name><name name-style="western"><surname>Qureshi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Erickson</surname><given-names>S.B.</given-names></name></person-group><article-title>Hospital-Acquired Dysmagnesemia and In-Hospital Mortality</article-title><source>Med. Sci.</source><year>2020</year><volume>8</volume><elocation-id>37</elocation-id><pub-id pub-id-type="doi">10.3390/medsci8030037</pub-id><pub-id pub-id-type="pmcid">PMC7565056</pub-id><pub-id pub-id-type="pmid">32882826</pub-id></element-citation></ref><ref id="B33-jcm-12-05157"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hansson</surname><given-names>F.</given-names></name><name name-style="western"><surname>Klarin</surname><given-names>B.</given-names></name></person-group><article-title>Analysis of hypo- and hypermagnesemia in an intensive care unit cohort</article-title><source>Acta Anaesthesiol. Scand.</source><year>2018</year><volume>62</volume><fpage>648</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1111/aas.13061</pub-id><pub-id pub-id-type="pmid">29341068</pub-id></element-citation></ref><ref id="B34-jcm-12-05157"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noronha</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Matuschak</surname><given-names>G.M.</given-names></name></person-group><article-title>Magnesium in critical illness: Metabolism, assessment, and treatment</article-title><source>Intensive Care Med.</source><year>2002</year><volume>28</volume><fpage>667</fpage><lpage>679</lpage><pub-id pub-id-type="pmid">12107669</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00134-002-1281-y</pub-id></element-citation></ref><ref id="B35-jcm-12-05157"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wahr</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vender</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>H.C.</given-names></name><name name-style="western"><surname>Spiess</surname><given-names>B.</given-names></name><name name-style="western"><surname>Horrow</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Maddi</surname><given-names>R.</given-names></name></person-group><article-title>Effect of propofol with and without EDTA on haemodynamics and calcium and magnesium homeostasis during and after cardiac surgery</article-title><source>Intensiv. Care Med.</source><year>2000</year><volume>26</volume><issue>(Suppl. S4)</issue><fpage>S443</fpage><lpage>S451</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/pl00003788</pub-id><pub-id pub-id-type="pmid">11310907</pub-id></element-citation></ref><ref id="B36-jcm-12-05157"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herr</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Ulatowski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fulda</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Cason</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hickey</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nejman</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Zaloga</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Teres</surname><given-names>D.</given-names></name></person-group><article-title>Safety and Efficacy of Propofol with EDTA When Used for Sedation of Surgical Intensive Care Unit Patients</article-title><source>Intensiv. Care Med.</source><year>2000</year><volume>26</volume><issue>(Suppl. S4)</issue><fpage>S452</fpage><lpage>S462</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/pl00003789</pub-id><pub-id pub-id-type="pmid">11310908</pub-id></element-citation></ref><ref id="B37-jcm-12-05157"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barr</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zaloga</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Haupt</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Weinmann</surname><given-names>M.</given-names></name><name name-style="western"><surname>Murray</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Bandi</surname><given-names>V.</given-names></name><name name-style="western"><surname>Teres</surname><given-names>D.</given-names></name></person-group><article-title>Cation metabolism during propofol sedation with and without EDTA in patients with impaired renal function</article-title><source>Intensiv. Care Med.</source><year>2000</year><volume>26</volume><issue>(Suppl. S4)</issue><fpage>S433</fpage><lpage>S442</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/pl00003787</pub-id><pub-id pub-id-type="pmid">11310906</pub-id></element-citation></ref><ref id="B38-jcm-12-05157"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kieboom</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Zietse</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ikram</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Hoorn</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Stricker</surname><given-names>B.H.</given-names></name></person-group><article-title>Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population</article-title><source>Pharmacoepidemiol. Drug Saf.</source><year>2018</year><volume>27</volume><fpage>1166</fpage><lpage>1173</lpage><pub-id pub-id-type="doi">10.1002/pds.4636</pub-id><pub-id pub-id-type="pmid">30095199</pub-id></element-citation></ref><ref id="B39-jcm-12-05157"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pasala</surname><given-names>S.</given-names></name><name name-style="western"><surname>Carmody</surname><given-names>J.B.</given-names></name></person-group><article-title>How to use&#8230; serum creatinine, cystatin C and GFR</article-title><source>Arch. Dis. Child. Educ. Pract. Ed.</source><year>2017</year><volume>102</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">27647862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/archdischild-2016-311062</pub-id></element-citation></ref><ref id="B40-jcm-12-05157"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Felsenfeld</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Levine</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>M.</given-names></name></person-group><article-title>Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease</article-title><source>Semin. Dial.</source><year>2015</year><volume>28</volume><fpage>564</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1111/sdi.12411</pub-id><pub-id pub-id-type="pmid">26303319</pub-id></element-citation></ref><ref id="B41-jcm-12-05157"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coburn</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Popovtzer</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Massry</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Kleeman</surname><given-names>C.R.</given-names></name></person-group><article-title>The physicochemical state and renal handling of divalent ions in chronic renal failure</article-title><source>Arch. Intern. Med.</source><year>1969</year><volume>124</volume><fpage>302</fpage><lpage>311</lpage><pub-id pub-id-type="pmid">5806042</pub-id></element-citation></ref><ref id="B42-jcm-12-05157"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laupland</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Tabah</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ramanan</surname><given-names>M.</given-names></name></person-group><article-title>Determinants of serum magnesium abnormalities and outcome among admissions to the intensive care unit</article-title><source>Anaesth. Crit. Care Pain Med.</source><year>2020</year><volume>39</volume><fpage>793</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1016/j.accpm.2020.07.020</pub-id><pub-id pub-id-type="pmid">33059107</pub-id></element-citation></ref><ref id="B43-jcm-12-05157"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malinowska</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ma&#322;ecka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ciepiela</surname><given-names>O.</given-names></name></person-group><article-title>Variations in Magnesium Concentration Are Associated with Increased Mortality: Study in an Unselected Population of Hospitalized Patients</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><fpage>1836</fpage><pub-id pub-id-type="pmid">32575600</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/nu12061836</pub-id><pub-id pub-id-type="pmcid">PMC7353204</pub-id></element-citation></ref><ref id="B44-jcm-12-05157"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Angkananard</surname><given-names>T.</given-names></name><name name-style="western"><surname>Anothaisintawee</surname><given-names>T.</given-names></name><name name-style="western"><surname>Eursiriwan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gorelik</surname><given-names>O.</given-names></name><name name-style="western"><surname>McEvoy</surname><given-names>M.</given-names></name><name name-style="western"><surname>Attia</surname><given-names>J.</given-names></name><name name-style="western"><surname>Thakkinstian</surname><given-names>A.</given-names></name></person-group><article-title>The association of serum magnesium and mortality outcomes in heart failure patients: A systematic review and meta-analysis</article-title><source>Medicine</source><year>2016</year><volume>95</volume><fpage>e5406</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000005406</pub-id><pub-id pub-id-type="pmid">27977579</pub-id><pub-id pub-id-type="pmcid">PMC5268025</pub-id></element-citation></ref><ref id="B45-jcm-12-05157"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tyler</surname><given-names>L.N.</given-names></name></person-group><article-title>Transfusion of blood and blood products: Indications and complications</article-title><source>Am. Fam. Physician</source><year>2011</year><volume>83</volume><fpage>719</fpage><lpage>724</lpage><pub-id pub-id-type="pmid">21404983</pub-id></element-citation></ref><ref id="B46-jcm-12-05157"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lichtiger</surname><given-names>B.</given-names></name><name name-style="western"><surname>Perry-Thornton</surname><given-names>E.</given-names></name></person-group><article-title>Hemolytic transfusion reactions in oncology patients: Experience in a large cancer center</article-title><source>J. Clin. Oncol.</source><year>1984</year><volume>2</volume><fpage>438</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1200/JCO.1984.2.5.438</pub-id><pub-id pub-id-type="pmid">6726297</pub-id></element-citation></ref><ref id="B47-jcm-12-05157"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poder</surname><given-names>T.G.</given-names></name><name name-style="western"><surname>Nonkani</surname><given-names>W.G.</given-names></name><name name-style="western"><surname>Leponkouo</surname><given-names>&#201;.T.</given-names></name></person-group><article-title>Blood Warming and Hemolysis: A Systematic Review with Me-ta-Analysis</article-title><source>Transfus. Med. Rev.</source><year>2015</year><volume>29</volume><fpage>172</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.tmrv.2015.03.002</pub-id><pub-id pub-id-type="pmid">25840802</pub-id></element-citation></ref><ref id="B48-jcm-12-05157"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romani</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Scarpa</surname><given-names>A.</given-names></name></person-group><article-title>Regulation of cellular magnesium</article-title><source>Front. Biosci.</source><year>2000</year><volume>5</volume><fpage>d720-34</fpage><pub-id pub-id-type="doi">10.2741/Romani</pub-id><pub-id pub-id-type="pmid">10922296</pub-id></element-citation></ref><ref id="B49-jcm-12-05157"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van de Watering</surname><given-names>L.M.</given-names></name></person-group><article-title>Age of blood: Does older blood yield poorer outcomes?</article-title><source>Curr. Opin. Hematol.</source><year>2013</year><volume>20</volume><fpage>526</fpage><lpage>532</lpage><pub-id pub-id-type="pmid">24104414</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MOH.0b013e328365aa3a</pub-id></element-citation></ref><ref id="B50-jcm-12-05157"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Meer</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Cancelas</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Cardigan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Devine</surname><given-names>D.V.</given-names></name><name name-style="western"><surname>Gulliksson</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sparrow</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Vassallo</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>de Wildt-Eggen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Baumann-Baretti</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hess</surname><given-names>J.R.</given-names></name></person-group><article-title>Evaluation of overnight hold of whole blood at room temperature before component processing: Effect of red blood cell (RBC) additive solutions on in vitro RBC measures</article-title><source>Transfusion</source><year>2011</year><volume>51</volume><issue>(Suppl. S1)</issue><fpage>15s</fpage><lpage>24s</lpage><pub-id pub-id-type="pmid">21223291</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1537-2995.2010.02959.x</pub-id></element-citation></ref><ref id="B51-jcm-12-05157"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sparrow</surname><given-names>R.L.</given-names></name></person-group><article-title>Time to revisit red blood cell additive solutions and storage conditions: A role for &#8220;omics&#8221; analyses</article-title><source>Blood Transfus.</source><year>2012</year><volume>10</volume><issue>(Suppl. S2)</issue><fpage>s7</fpage><lpage>s11</lpage><pub-id pub-id-type="pmid">22890271</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2450/2012.003S</pub-id><pub-id pub-id-type="pmcid">PMC3418618</pub-id></element-citation></ref><ref id="B52-jcm-12-05157"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dopsaj</surname><given-names>V.</given-names></name><name name-style="western"><surname>Martinovic</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dopsaj</surname><given-names>M.</given-names></name><name name-style="western"><surname>Stevuljevic</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Bogavac-Stanojevic</surname><given-names>N.</given-names></name></person-group><article-title>Gender-Specific Oxidative Stress Parameters</article-title><source>Int. J. Sports Med.</source><year>2010</year><volume>32</volume><fpage>14</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1055/s-0030-1267930</pub-id><pub-id pub-id-type="pmid">21086243</pub-id></element-citation></ref><ref id="B53-jcm-12-05157"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maturu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Varadacharyulu</surname><given-names>N.</given-names></name></person-group><article-title>Adaptive changes in fatty acid profile of erythrocyte membrane in relation to plasma and red cell metabolic changes in chronic alcoholic men</article-title><source>Hum. Exp. Toxicol.</source><year>2012</year><volume>31</volume><fpage>652</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1177/0960327111432504</pub-id><pub-id pub-id-type="pmid">22249389</pub-id></element-citation></ref><ref id="B54-jcm-12-05157"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Padmavathi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>V.D.</given-names></name><name name-style="western"><surname>Kavitha</surname><given-names>G.</given-names></name><name name-style="western"><surname>Paramahamsa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Varadacharyulu</surname><given-names>N.</given-names></name></person-group><article-title>Chronic cigarette smoking alters erythrocyte membrane lipid composition and properties in male human volunteers</article-title><source>Nitric Oxide</source><year>2010</year><volume>23</volume><fpage>181</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.niox.2010.05.287</pub-id><pub-id pub-id-type="pmid">20561918</pub-id></element-citation></ref><ref id="B55-jcm-12-05157"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raval</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Waters</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Seltsam</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scharberg</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Richter</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kameneva</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Yazer</surname><given-names>M.H.</given-names></name></person-group><article-title>Menopausal status affects the susceptibility of stored RBCs to mechanical stress</article-title><source>Vox Sang.</source><year>2011</year><volume>100</volume><fpage>418</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1111/j.1423-0410.2010.01439.x</pub-id><pub-id pub-id-type="pmid">21488881</pub-id></element-citation></ref><ref id="B56-jcm-12-05157"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hess</surname><given-names>J.R.</given-names></name></person-group><article-title>Measures of stored red blood cell quality</article-title><source>Vox Sang.</source><year>2014</year><volume>107</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/vox.12130</pub-id><pub-id pub-id-type="pmid">24446817</pub-id></element-citation></ref><ref id="B57-jcm-12-05157"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fiorentini</surname><given-names>D.</given-names></name><name name-style="western"><surname>Cappadone</surname><given-names>C.</given-names></name><name name-style="western"><surname>Farruggia</surname><given-names>G.</given-names></name><name name-style="western"><surname>Prata</surname><given-names>C.</given-names></name></person-group><article-title>Magnesium: Biochemistry, Nutrition, Detection, and Social Impact of Diseases Linked to Its Deficiency</article-title><source>Nutrients</source><year>2021</year><volume>13</volume><elocation-id>1136</elocation-id><pub-id pub-id-type="doi">10.3390/nu13041136</pub-id><pub-id pub-id-type="pmid">33808247</pub-id><pub-id pub-id-type="pmcid">PMC8065437</pub-id></element-citation></ref><ref id="B58-jcm-12-05157"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Baaij</surname><given-names>J.H.F.</given-names></name><name name-style="western"><surname>Hoenderop</surname><given-names>J.G.J.</given-names></name><name name-style="western"><surname>Bindels</surname><given-names>R.J.</given-names></name></person-group><article-title>Magnesium in Man: Implications for Health and Disease</article-title><source>Physiol. Rev.</source><year>2015</year><volume>95</volume><fpage>1</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1152/physrev.00012.2014</pub-id><pub-id pub-id-type="pmid">25540137</pub-id></element-citation></ref><ref id="B59-jcm-12-05157"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pickering</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mazur</surname><given-names>A.</given-names></name><name name-style="western"><surname>Trousselard</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bienkowski</surname><given-names>P.</given-names></name><name name-style="western"><surname>Yaltsewa</surname><given-names>N.</given-names></name><name name-style="western"><surname>Amessou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Noah</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pouteau</surname><given-names>E.</given-names></name></person-group><article-title>Magnesium Status and Stress: The Vicious Circle Concept Revisited</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>3672</elocation-id><pub-id pub-id-type="doi">10.3390/nu12123672</pub-id><pub-id pub-id-type="pmid">33260549</pub-id><pub-id pub-id-type="pmcid">PMC7761127</pub-id></element-citation></ref><ref id="B60-jcm-12-05157"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galland</surname><given-names>L.</given-names></name></person-group><article-title>Magnesium, stress and neuropsychiatric disorders</article-title><source>Magnes. Trace Elem.</source><year>1991</year><volume>10</volume><fpage>287</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">1844561</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="jcm-12-05157-f001" orientation="portrait"><label>Figure 1</label><caption><p>(<bold>A</bold>) The difference in the total serum magnesium concentration between preoperative and 24 h postoperative values (<italic toggle="yes">p</italic> &lt; 0.00001). (<bold>B</bold>) The difference in the total serum magnesium concentration between preoperative and 48 h postoperative values (<italic toggle="yes">p</italic> &lt; 0.00001).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-12-05157-g001.jpg"/></fig><fig position="float" id="jcm-12-05157-f002" orientation="portrait"><label>Figure 2</label><caption><p>Differences in the hypermagnesemia incidence before the massive transfusion and 24 h and 48 h postoperatively.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-12-05157-g002.jpg"/></fig><fig position="float" id="jcm-12-05157-f003" orientation="portrait"><label>Figure 3</label><caption><p>(<bold>A</bold>) Mean serum magnesium concentration depending on the outcome 24 h and 48 h postoperatively (<italic toggle="yes">p</italic> &lt; 0.05). (<bold>B</bold>) The difference in hypermagnesemia prevalence between patients who died and survived 24 h postoperatively (<italic toggle="yes">p</italic> &lt; 0.05). (<bold>C</bold>) The difference in hypermagnesemia prevalence between patients who died and survived 48 h postoperatively (<italic toggle="yes">p</italic> &lt; 0.05).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-12-05157-g003.jpg"/></fig><table-wrap position="float" id="jcm-12-05157-t001" orientation="portrait"><object-id pub-id-type="pii">jcm-12-05157-t001_Table 1</object-id><label>Table 1</label><caption><p>Basic information regarding patients, serum magnesium concentration, and transfused packed RBCs in the study group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reason for Hospitalization</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Drugs Administered Intravenously during Hospitalization</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dialysis</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chronic Diseases</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Survival</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Preoperative Mg Concentration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">24 h Postoperative Mg Concentration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">48 h Postoperative Mg Concentration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RBCs Approximate Volume [mL]</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">The Mean Intracellular Concentration in Transfused RBCs</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multi-site trauma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Propofol, <break/>sufentanil, tazocin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol dependence syndrome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.04</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.325</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tight aortic stenosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biotraxon, lenovor, amiodarone, furosemide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypertension</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.85</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe vitamin B<sub>12</sub> deficiency anemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p-ANCA systemic vasculitis, hypertension, chronic kidney disease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.424</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hemorrhage of the digestive tract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Midanium, norepinephrine, adrenalin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol dependence syndrome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.96</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.34</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Laparotomy due to disseminated cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Levonor, morphine, furosemide, meronem</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nonalcoholic steatohepatitis, portal hypertension, hepatic encephalopathy, t2 diabetes mellitus, hypertension, obesity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.78</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.62</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver transplant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inflammatory bowel disease, hypothyroidism</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.81</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.028</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver retransplantation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metronidazole</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Renal failure, recurrent cholangitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.71</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.89</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.55</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe aortic stenosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furosemide, insulin, tramadol, propofol, sufentanil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.77</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.705</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ascending aortic aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biofazolin, propofol, sulfentanyl, furosemide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypertension</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.42</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.59333</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insufficiency of the main artery valve</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adrenaline, norepinephrine, dobutamine, levosimendan, propofol, midazolam, sufentanil, morphine, furosemide, heparin, coradrone, lignocaine, biotraxone, antithrombin III, PPI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heart failure, ascending aortic aneurysm, permanent atrial fibrillation, hypertension</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.525</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aortic valve disease and coronary artery disease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Propofol, sulfentanyl, furosemide, ebrantil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypertension, hyperlipidemia, t2 diabetes mellitus, COPD, heart failure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.04</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.16</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver transplantation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unfractionated heparin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.85</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.74</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Replacement of the aortic valve with the ascending aorta</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Propofol, sulfentanyl, levonor, dobutamine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aortic regurgitation, ischemic heart disease, heart failure, hypertension, thyroid nodular goiter</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.06</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.86</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bleeding from esophageal varices</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terlipressin, PPI, K supplementation, insulin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver failure, pancreatic head tumor infiltrating the bile ducts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.04</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.475</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe iron deficiency anemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clonazepam, furosemide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe microcytic anemia, hypertension, atherosclerosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.03</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2400</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.58</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sideropenic anemia caused by recurrent bleeding from hemorrhoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothyroidism</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.02</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.72</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcoholic cirrhosis of the liver</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Norepinephrine, anti-encephalopathic drugs, antibiotic, propofol, sufentanil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol dependence syndrome, esophageal varices</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.96</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.38</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abdominal pain after subtotal gastrectomy for gastric adenoma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Propofol, sufentanil, antibiotic, furosemide, norepinephrine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothyroidism, diverticular disease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.76</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.31</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dissecting aneurysm of the main artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Propofol, morphine, noradrenaline, epinephrine, glypressin, polfilin, meronem, vancomycin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Loeys&#8211;Dietz syndrome, hypertension, asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.81</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.04</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.476</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pancreatic cancer disseminated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrocortisone, clemastine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.585</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dissection of the ascending aorta</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tramadol, trifas, biofazolin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypertension, aortic regurgitation, hypothyroidism</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.04</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.605</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iron deficiency anemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Venofer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypertension</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2400</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.04</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decompensated liver cirrhosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ovarian cancer, portal vein thrombosis, hemorrhoids, depression</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.68</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.72</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.23</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe nosebleed after the completion of chemotherapy for sarcoma of the hip</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothyroidism</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.03</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.425</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mitral valve defect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vancomycin, cordarone, concor cor <break/>amiodarone, trifas</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heart failure, ventricular arrhythmias, dyslipidemia,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.93</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.97</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cerebellar tumor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tazocin, vancomycin, ceftriaxone, amikacin, analgesics</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypertension, gastroesophageal reflux</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.04</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2400</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.265</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcoholic cirrhosis of the liver</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vancomycin, analgesics, anti-encephalopathic drugs, anti-coagulants</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CKD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.75</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.91</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.985</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Progressive liver damage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Propofol, norepinephrine, <break/>fluconazole</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.71</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.46</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iron and vitamin B<sub>12</sub> deficiency anemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypertension, hyperlipidemia, impaired fasting glucose</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.85</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.92</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.855</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatic failure in the course of PBC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diuretics, norepinephrine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pancreatic tail cyst, kidney cysts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.828</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver transplant for secondary biliary cirrhosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diuretics, norepinephrine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.872</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multiple myeloma, kappa light chain disease, ISS 3, D-S IIIB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypertension, CDK</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.04</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.724</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inflammation of the bile ducts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Morphine, midanium, norepinephrine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ulcerative colitis in remission</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.91</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.888</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver transplantation due to HCV infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sufentanil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypertension</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.85</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.825</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe symptoms of cholestasis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Proton-pump inhibitors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heart failure, hepatic steatosis and failure, hypertension</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.63</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.71</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.83667</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver transplantation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver transplantation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prograph, Augmentin MFF, prednisolone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T2 diabetes mellitus, thrombosis of the portal system</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.79</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.84</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.03</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.928</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Left lung nodule biopsy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypertension, diverticular disease, nephrolithiasis, atherosclerosis,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.03</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.908</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver transplantation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vancomycin, analgesics, anti-encephalopathic drugs, anti-coagulants</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Renal failure, ascites, hemorrhagic diathesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.91</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.772</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Progressive liver damage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Propofol, norepinephrine, <break/>fluconazole</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.97</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.91</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.04</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9075</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pulmonary embolism</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Extensive ulceration of the duodenal bulb, gastric hernia, liver cyst, diverticular disease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.744</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver transplantation due to toxic damage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sufentanil, midazolam, norepinephrine, colistin, </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.76</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Primary sclerosing cholangitis and chronic liver failure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Analgesics, norepinephrine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kidney failure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.893</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver transplant </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Analgesics</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Esophageal varices, anemia, chronic pancreatitis, hypertension, diabetes mellitus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.07</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rectal perforation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Analgesics</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cirrhosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.793</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute kidney injury and tacrolimus poisoning</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diuretics, meropenem, diflucan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Depression, acute renal failure, hypertension, alcohol dependence syndrome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.75</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cirrhosis and primary sclerosing cholangitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pressor amines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Esophageal varices, Graves&#8217; disease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.78</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2950</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.723</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inflammation and deterioration of kidney function</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tacrolimus, pressor amines, propofol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.31</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.873</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatic encephalopathy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Portal hypertension, splenomegaly, thrombocytopenia, chronic pancreatitis, diabetes mellitus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.67</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.89</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.68</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.572</td></tr></tbody></table></table-wrap><table-wrap position="float" id="jcm-12-05157-t002" orientation="portrait"><object-id pub-id-type="pii">jcm-12-05157-t002_Table 2</object-id><label>Table 2</label><caption><p>The association between the presence of factors potentially affecting magnesium homeostasis and the serum magnesium concentration preoperatively, 24 h postoperatively, and 48 h postoperatively.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Factors Potentially Affecting Magnesium Homeostasis</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Preoperatively</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">24 h Postoperatively</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">48 h Postoperatively</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Surgery</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.29</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.88</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.09</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Comorbidities</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.11</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.99</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.88</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Intravenous administration of sedatives</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.55</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &lt; 0.05</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &lt; 0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Intravenous administration of diuretics</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.11</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &lt; 0.05</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &lt; 0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Intravenous administration of antimicrobials</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.57</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.43</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dialysis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.65</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> = 0.78</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>